WO2024028816 - OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS REDUCTION AGENT
National phase entry:
Publication Number
WO/2024/028816
Publication Date
08.02.2024
International Application No.
PCT/IB2023/057883
International Filing Date
03.08.2023
Title **
[English]
OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS REDUCTION AGENT
[French]
COMPOSITION OPHTALMIQUE COMPRENANT DE LA PILOCARPINE ET UN AGENT DE RÉDUCTION DE LA ROUGEUR
Applicants **
BAUSCH + LOMB IRELAND LIMITED
Inventors
MARLOWE, Zora
COFFEY, Martin
Priority Data
63/370,427
04.08.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4078 | |
| EPO | Filing, Examination, Granting | 62263 | |
| Japan | Filing, Examination, Granting | 4097 | |
| South Korea | Filing, Examination, Granting | 6012 | |
| USA | Filing, Examination, Granting | 22940 |
Total:
99,390
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Ophthalmic compositions comprising an pilocarpine or a pharmaceutically acceptable salt thereof and a redness reduction agent, such as brimonidine or a pharmaceutically acceptable salt thereof, and an optional anti-allergen for treating presbyopia and/or night vision and redness in a single composition. The ophthalmic compositions may be provided in a container closure system, such as a low density polyethylene bottle. Container closure systems and kits comprising the ophthalmic compositions are disclosed.[French]
Compositions ophtalmiques comprenant une pilocarpine ou un sel pharmaceutiquement acceptable de celle-ci et un agent de réduction de la rougeur, tel que la brimonidine ou un sel pharmaceutiquement acceptable de celle-ci, et un anti-allergène facultatif pour traiter la presbytie et/ou la vision nocturne et la rougeur dans une seule composition. Les compositions ophtalmiques peuvent être présentes dans un système de fermeture de récipient, telle qu'une bouteille en polyéthylène basse densité. L'invention concerne également des systèmes de fermeture de récipient et des kits comprenant les compositions ophtalmiques.